PK Study of IV Formulation of GW856553

Clinical trial NCT01039961 · COMPLETED

Trial details

NCT number: NCT01039961
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2010-02-02
Primary completion: 2010-04-15
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.